We are live on ! Find out more
AIM

Arcadia Investment Management Portfolio holdings

AUM $584M
1-Year Est. Return 21.44%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+21.44%
3 Year Est. Return
+83.48%
5 Year Est. Return
+113.71%
10 Year Est. Return
+434.1%
AUM
$317M
AUM Growth
+$11M
Cap. Flow
-$4.86M
Cap. Flow %
-1.54%
Top 10 Hldgs %
26.67%
Holding
446
New
126
Increased
54
Reduced
78
Closed
19

Sector Composition

Rank Sector Weight
1 Technology 19.28%
2 Healthcare 14.17%
3 Consumer Discretionary 12.87%
4 Industrials 12.82%
5 Financials 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCBC
326
DELISTED
Macatawa Bank Corp
MCBC
$20K 0.01%
2,000
IPHI
327
DELISTED
INPHI CORPORATION
IPHI
$20K 0.01%
+417
New +$19.5K
AGN
328
DELISTED
Allergan plc
AGN
$20K 0.01%
85
-500
-85% -$116K
CGI
329
DELISTED
Celadon Group Inc
CGI
$20K 0.01%
+3,000
New +$24.5K
FIVE icon
330
Five Below
FIVE
$13.5B
$19K 0.01%
+428
New +$17K
INGN icon
331
Inogen
INGN
$164M
$19K 0.01%
+239
New +$16.6K
GAP
332
The Gap Inc
GAP
$7.37B
$19K 0.01%
788
SUM
333
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$19K 0.01%
+773
New +$18.1K
COHR
334
DELISTED
Coherent Inc
COHR
$19K 0.01%
+91
New +$15.9K
EXP icon
335
Eagle Materials
EXP
$6.57B
$18K 0.01%
+182
New +$18.6K
NEO icon
336
NeoGenomics
NEO
$2.13B
$18K 0.01%
+2,241
New +$18.3K
SRC
337
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$18K 0.01%
390
AMAG
338
DELISTED
AMAG Pharmaceuticals
AMAG
$18K 0.01%
+780
New +$18.7K
C icon
339
Citigroup
C
$226B
$17K 0.01%
280
GSK icon
340
GSK
GSK
$106B
$17K 0.01%
325
VRTX icon
341
Vertex Pharmaceuticals
VRTX
$126B
$17K 0.01%
160
ASNA
342
DELISTED
Ascena Retail Group, Inc.
ASNA
$17K 0.01%
+195
New +$18.7K
AXDX
343
DELISTED
Accelerate Diagnostics
AXDX
$16K 0.01%
+65
New +$14.8K
MCHX icon
344
Marchex
MCHX
$79.7M
$16K 0.01%
+5,800
New +$15.6K
EGHT icon
345
8x8 Inc
EGHT
$332M
$15K ﹤0.01%
+1,009
New +$15.3K
WBD icon
346
Warner Bros
WBD
$67.1B
$15K ﹤0.01%
500
MB
347
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
$15K ﹤0.01%
+557
New +$14.3K
RDNT icon
348
RadNet
RDNT
$5.69B
$14K ﹤0.01%
+2,400
New +$14.3K
RL icon
349
Ralph Lauren
RL
$23.6B
$14K ﹤0.01%
175
TREX icon
350
Trex
TREX
$5.01B
$14K ﹤0.01%
+796
New +$13.7K

Similar funds

Arcadia Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Arcadia Investment Management held 446 positions worth $317M, up 3.6% from $306M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Arcadia Investment Management's Q1 2017 filing shows 126 new, 54 increased, 78 reduced and 19 closed positions. Its largest new stake was LogMein, Inc.: 6,444 shares worth $628K. The largest sale was Stryker, an estimated $1.4M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Arcadia Investment Management's largest Q1 2017 buy was LogMein, Inc.: 6,444 shares worth $628K.
  • Arcadia Investment Management added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q1 2017, an estimated $885K increase.
  • Arcadia Investment Management's biggest Q1 2017 reduction was Stryker, cutting an estimated $1.4M.
  • Arcadia Investment Management fully exited HF Sinclair in Q1 2017, selling an estimated $197K.
  • Arcadia Investment Management's ten largest holdings make up 27% of its $317M portfolio in Q1 2017.
  • Arcadia Investment Management opened 126 new positions and closed 19 in Q1 2017.
  • Arcadia Investment Management's portfolio value rose 3.6% quarter-over-quarter to $317M.

Based on Arcadia Investment Management's 13F filing for Q1 2017, filed 28 Apr 2017.